Loading…
Alternative Analysis Methods for Time to Event Endpoints under Non-proportional Hazards: A Comparative Analysis
The log-rank test is most powerful under proportional hazards (PH). In practice, non-PH patterns are often observed in clinical trials, such as in immuno-oncology; therefore, alternative methods are needed to restore the efficiency of statistical testing. Three categories of testing methods were eva...
Saved in:
Published in: | arXiv.org 2019-09 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | |
container_start_page | |
container_title | arXiv.org |
container_volume | |
creator | Lin, Ray S Lin, Ji Roychoudhury, Satrajit Anderson, Keaven M Hu, Tianle Huang, Bo Leon, Larry F Liao, Jason JZ Liu, Rong Luo, Xiaodong Mukhopadhyay, Pralay Qin, Rui Tatsuoka, Kay Wang, Xuejing Wang, Yang Zhu, Jian Tai-Tsang, Chen Iacona, Renee Cross-Pharma Non-proportional Hazards Working Group |
description | The log-rank test is most powerful under proportional hazards (PH). In practice, non-PH patterns are often observed in clinical trials, such as in immuno-oncology; therefore, alternative methods are needed to restore the efficiency of statistical testing. Three categories of testing methods were evaluated, including weighted log-rank tests, Kaplan-Meier curve-based tests (including weighted Kaplan-Meier and Restricted Mean Survival Time, RMST), and combination tests (including Breslow test, Lee's combo test, and MaxCombo test). Nine scenarios representing the PH and various non-PH patterns were simulated. The power, type I error, and effect estimates of each method were compared. In general, all tests control type I error well. There is not a single most powerful test across all scenarios. In the absence of prior knowledge regarding the PH or non-PH patterns, the MaxCombo test is relatively robust across patterns. Since the treatment effect changes overtime under non-PH, the overall profile of the treatment effect may not be represented comprehensively based on a single measure. Thus, multiple measures of the treatment effect should be pre-specified as sensitivity analyses to evaluate the totality of the data. |
doi_str_mv | 10.48550/arxiv.1909.09467 |
format | article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2295838481</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2295838481</sourcerecordid><originalsourceid>FETCH-LOGICAL-a521-ef781281fc4cc2a85303d06d43d7c67171242cc26cb186926c6bd0830e46e77a3</originalsourceid><addsrcrecordid>eNpVj89LwzAAhYMgOOb-AG8Bz635ndRbKdMNpl56H1mTYkaX1CQt6l9vQS-evsPjfbwHwB1GJVOcowcdP91c4gpVJaqYkFdgRSjFhWKE3IBNSmeEEBGScE5XINRDttHr7GYLa6-Hr-QSfLH5PZgE-xBh6y4W5gC3s_UZbr0Zg_M5wckbG-Fr8MUYwxhidmGpw53-1tGkR1jDJlxGHf-rb8F1r4dkN39cg_Zp2za74vD2vG_qQ6E5wYXtpcJE4b5jXUe04hRRg4Rh1MhOSCwxYWRJRHfCSlQLxckgRZFlwkqp6Rrc_2qXbR-TTfl4DtNyc0hHQiquqGIK0x8ijluS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2295838481</pqid></control><display><type>article</type><title>Alternative Analysis Methods for Time to Event Endpoints under Non-proportional Hazards: A Comparative Analysis</title><source>Publicly Available Content Database</source><creator>Lin, Ray S ; Lin, Ji ; Roychoudhury, Satrajit ; Anderson, Keaven M ; Hu, Tianle ; Huang, Bo ; Leon, Larry F ; Liao, Jason JZ ; Liu, Rong ; Luo, Xiaodong ; Mukhopadhyay, Pralay ; Qin, Rui ; Tatsuoka, Kay ; Wang, Xuejing ; Wang, Yang ; Zhu, Jian ; Tai-Tsang, Chen ; Iacona, Renee ; Cross-Pharma Non-proportional Hazards Working Group</creator><creatorcontrib>Lin, Ray S ; Lin, Ji ; Roychoudhury, Satrajit ; Anderson, Keaven M ; Hu, Tianle ; Huang, Bo ; Leon, Larry F ; Liao, Jason JZ ; Liu, Rong ; Luo, Xiaodong ; Mukhopadhyay, Pralay ; Qin, Rui ; Tatsuoka, Kay ; Wang, Xuejing ; Wang, Yang ; Zhu, Jian ; Tai-Tsang, Chen ; Iacona, Renee ; Cross-Pharma Non-proportional Hazards Working Group</creatorcontrib><description>The log-rank test is most powerful under proportional hazards (PH). In practice, non-PH patterns are often observed in clinical trials, such as in immuno-oncology; therefore, alternative methods are needed to restore the efficiency of statistical testing. Three categories of testing methods were evaluated, including weighted log-rank tests, Kaplan-Meier curve-based tests (including weighted Kaplan-Meier and Restricted Mean Survival Time, RMST), and combination tests (including Breslow test, Lee's combo test, and MaxCombo test). Nine scenarios representing the PH and various non-PH patterns were simulated. The power, type I error, and effect estimates of each method were compared. In general, all tests control type I error well. There is not a single most powerful test across all scenarios. In the absence of prior knowledge regarding the PH or non-PH patterns, the MaxCombo test is relatively robust across patterns. Since the treatment effect changes overtime under non-PH, the overall profile of the treatment effect may not be represented comprehensively based on a single measure. Thus, multiple measures of the treatment effect should be pre-specified as sensitivity analyses to evaluate the totality of the data.</description><identifier>EISSN: 2331-8422</identifier><identifier>DOI: 10.48550/arxiv.1909.09467</identifier><language>eng</language><publisher>Ithaca: Cornell University Library, arXiv.org</publisher><subject>Hazards ; Rank tests ; Sensitivity analysis</subject><ispartof>arXiv.org, 2019-09</ispartof><rights>2019. This work is published under http://arxiv.org/licenses/nonexclusive-distrib/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2295838481?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>776,780,25731,27902,36989,44566</link.rule.ids></links><search><creatorcontrib>Lin, Ray S</creatorcontrib><creatorcontrib>Lin, Ji</creatorcontrib><creatorcontrib>Roychoudhury, Satrajit</creatorcontrib><creatorcontrib>Anderson, Keaven M</creatorcontrib><creatorcontrib>Hu, Tianle</creatorcontrib><creatorcontrib>Huang, Bo</creatorcontrib><creatorcontrib>Leon, Larry F</creatorcontrib><creatorcontrib>Liao, Jason JZ</creatorcontrib><creatorcontrib>Liu, Rong</creatorcontrib><creatorcontrib>Luo, Xiaodong</creatorcontrib><creatorcontrib>Mukhopadhyay, Pralay</creatorcontrib><creatorcontrib>Qin, Rui</creatorcontrib><creatorcontrib>Tatsuoka, Kay</creatorcontrib><creatorcontrib>Wang, Xuejing</creatorcontrib><creatorcontrib>Wang, Yang</creatorcontrib><creatorcontrib>Zhu, Jian</creatorcontrib><creatorcontrib>Tai-Tsang, Chen</creatorcontrib><creatorcontrib>Iacona, Renee</creatorcontrib><creatorcontrib>Cross-Pharma Non-proportional Hazards Working Group</creatorcontrib><title>Alternative Analysis Methods for Time to Event Endpoints under Non-proportional Hazards: A Comparative Analysis</title><title>arXiv.org</title><description>The log-rank test is most powerful under proportional hazards (PH). In practice, non-PH patterns are often observed in clinical trials, such as in immuno-oncology; therefore, alternative methods are needed to restore the efficiency of statistical testing. Three categories of testing methods were evaluated, including weighted log-rank tests, Kaplan-Meier curve-based tests (including weighted Kaplan-Meier and Restricted Mean Survival Time, RMST), and combination tests (including Breslow test, Lee's combo test, and MaxCombo test). Nine scenarios representing the PH and various non-PH patterns were simulated. The power, type I error, and effect estimates of each method were compared. In general, all tests control type I error well. There is not a single most powerful test across all scenarios. In the absence of prior knowledge regarding the PH or non-PH patterns, the MaxCombo test is relatively robust across patterns. Since the treatment effect changes overtime under non-PH, the overall profile of the treatment effect may not be represented comprehensively based on a single measure. Thus, multiple measures of the treatment effect should be pre-specified as sensitivity analyses to evaluate the totality of the data.</description><subject>Hazards</subject><subject>Rank tests</subject><subject>Sensitivity analysis</subject><issn>2331-8422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpVj89LwzAAhYMgOOb-AG8Bz635ndRbKdMNpl56H1mTYkaX1CQt6l9vQS-evsPjfbwHwB1GJVOcowcdP91c4gpVJaqYkFdgRSjFhWKE3IBNSmeEEBGScE5XINRDttHr7GYLa6-Hr-QSfLH5PZgE-xBh6y4W5gC3s_UZbr0Zg_M5wckbG-Fr8MUYwxhidmGpw53-1tGkR1jDJlxGHf-rb8F1r4dkN39cg_Zp2za74vD2vG_qQ6E5wYXtpcJE4b5jXUe04hRRg4Rh1MhOSCwxYWRJRHfCSlQLxckgRZFlwkqp6Rrc_2qXbR-TTfl4DtNyc0hHQiquqGIK0x8ijluS</recordid><startdate>20190920</startdate><enddate>20190920</enddate><creator>Lin, Ray S</creator><creator>Lin, Ji</creator><creator>Roychoudhury, Satrajit</creator><creator>Anderson, Keaven M</creator><creator>Hu, Tianle</creator><creator>Huang, Bo</creator><creator>Leon, Larry F</creator><creator>Liao, Jason JZ</creator><creator>Liu, Rong</creator><creator>Luo, Xiaodong</creator><creator>Mukhopadhyay, Pralay</creator><creator>Qin, Rui</creator><creator>Tatsuoka, Kay</creator><creator>Wang, Xuejing</creator><creator>Wang, Yang</creator><creator>Zhu, Jian</creator><creator>Tai-Tsang, Chen</creator><creator>Iacona, Renee</creator><creator>Cross-Pharma Non-proportional Hazards Working Group</creator><general>Cornell University Library, arXiv.org</general><scope>8FE</scope><scope>8FG</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>HCIFZ</scope><scope>L6V</scope><scope>M7S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope></search><sort><creationdate>20190920</creationdate><title>Alternative Analysis Methods for Time to Event Endpoints under Non-proportional Hazards: A Comparative Analysis</title><author>Lin, Ray S ; Lin, Ji ; Roychoudhury, Satrajit ; Anderson, Keaven M ; Hu, Tianle ; Huang, Bo ; Leon, Larry F ; Liao, Jason JZ ; Liu, Rong ; Luo, Xiaodong ; Mukhopadhyay, Pralay ; Qin, Rui ; Tatsuoka, Kay ; Wang, Xuejing ; Wang, Yang ; Zhu, Jian ; Tai-Tsang, Chen ; Iacona, Renee ; Cross-Pharma Non-proportional Hazards Working Group</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a521-ef781281fc4cc2a85303d06d43d7c67171242cc26cb186926c6bd0830e46e77a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Hazards</topic><topic>Rank tests</topic><topic>Sensitivity analysis</topic><toplevel>online_resources</toplevel><creatorcontrib>Lin, Ray S</creatorcontrib><creatorcontrib>Lin, Ji</creatorcontrib><creatorcontrib>Roychoudhury, Satrajit</creatorcontrib><creatorcontrib>Anderson, Keaven M</creatorcontrib><creatorcontrib>Hu, Tianle</creatorcontrib><creatorcontrib>Huang, Bo</creatorcontrib><creatorcontrib>Leon, Larry F</creatorcontrib><creatorcontrib>Liao, Jason JZ</creatorcontrib><creatorcontrib>Liu, Rong</creatorcontrib><creatorcontrib>Luo, Xiaodong</creatorcontrib><creatorcontrib>Mukhopadhyay, Pralay</creatorcontrib><creatorcontrib>Qin, Rui</creatorcontrib><creatorcontrib>Tatsuoka, Kay</creatorcontrib><creatorcontrib>Wang, Xuejing</creatorcontrib><creatorcontrib>Wang, Yang</creatorcontrib><creatorcontrib>Zhu, Jian</creatorcontrib><creatorcontrib>Tai-Tsang, Chen</creatorcontrib><creatorcontrib>Iacona, Renee</creatorcontrib><creatorcontrib>Cross-Pharma Non-proportional Hazards Working Group</creatorcontrib><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Engineering Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><jtitle>arXiv.org</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, Ray S</au><au>Lin, Ji</au><au>Roychoudhury, Satrajit</au><au>Anderson, Keaven M</au><au>Hu, Tianle</au><au>Huang, Bo</au><au>Leon, Larry F</au><au>Liao, Jason JZ</au><au>Liu, Rong</au><au>Luo, Xiaodong</au><au>Mukhopadhyay, Pralay</au><au>Qin, Rui</au><au>Tatsuoka, Kay</au><au>Wang, Xuejing</au><au>Wang, Yang</au><au>Zhu, Jian</au><au>Tai-Tsang, Chen</au><au>Iacona, Renee</au><au>Cross-Pharma Non-proportional Hazards Working Group</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Alternative Analysis Methods for Time to Event Endpoints under Non-proportional Hazards: A Comparative Analysis</atitle><jtitle>arXiv.org</jtitle><date>2019-09-20</date><risdate>2019</risdate><eissn>2331-8422</eissn><abstract>The log-rank test is most powerful under proportional hazards (PH). In practice, non-PH patterns are often observed in clinical trials, such as in immuno-oncology; therefore, alternative methods are needed to restore the efficiency of statistical testing. Three categories of testing methods were evaluated, including weighted log-rank tests, Kaplan-Meier curve-based tests (including weighted Kaplan-Meier and Restricted Mean Survival Time, RMST), and combination tests (including Breslow test, Lee's combo test, and MaxCombo test). Nine scenarios representing the PH and various non-PH patterns were simulated. The power, type I error, and effect estimates of each method were compared. In general, all tests control type I error well. There is not a single most powerful test across all scenarios. In the absence of prior knowledge regarding the PH or non-PH patterns, the MaxCombo test is relatively robust across patterns. Since the treatment effect changes overtime under non-PH, the overall profile of the treatment effect may not be represented comprehensively based on a single measure. Thus, multiple measures of the treatment effect should be pre-specified as sensitivity analyses to evaluate the totality of the data.</abstract><cop>Ithaca</cop><pub>Cornell University Library, arXiv.org</pub><doi>10.48550/arxiv.1909.09467</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | EISSN: 2331-8422 |
ispartof | arXiv.org, 2019-09 |
issn | 2331-8422 |
language | eng |
recordid | cdi_proquest_journals_2295838481 |
source | Publicly Available Content Database |
subjects | Hazards Rank tests Sensitivity analysis |
title | Alternative Analysis Methods for Time to Event Endpoints under Non-proportional Hazards: A Comparative Analysis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T12%3A37%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Alternative%20Analysis%20Methods%20for%20Time%20to%20Event%20Endpoints%20under%20Non-proportional%20Hazards:%20A%20Comparative%20Analysis&rft.jtitle=arXiv.org&rft.au=Lin,%20Ray%20S&rft.date=2019-09-20&rft.eissn=2331-8422&rft_id=info:doi/10.48550/arxiv.1909.09467&rft_dat=%3Cproquest%3E2295838481%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a521-ef781281fc4cc2a85303d06d43d7c67171242cc26cb186926c6bd0830e46e77a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2295838481&rft_id=info:pmid/&rfr_iscdi=true |